User: Guest  Login
Title:

Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): Results of the randomized phase II INTEGA trial (AIO STO 0217)

Document type:
Meeting Abstract
Author(s):
Stein, A.; Paschold, L.; Tintelnot, J.; Goekkurt, E.; Thuss-Patience, P. C.; Lorenzen, S.; Ettrich, T. J.; Knorrenschild, J. Riera; Jacobasch, L.; Kretzschmar, A.; Kubicka, S.; Al-Batran, S-E.; Reinacher-Schick, A.; Pink, D.; Sinn, M.; Lindig, U.; Hinke, A.; Becker, S. Hegewisch; Binder, M.
Journal title abbreviation:
Ann Oncol
Year:
2021
Journal volume:
32 Suppl 5
Pages contribution:
S1331-S1331
Fulltext / DOI:
doi:10.1016/j.annonc.2021.08.2134
Print-ISSN:
0923-7534
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX